Lexapro and Tremfya drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lexapro (escitalopram oxalate) and Tremfya (guselkumab). Common drug interactions include drug ineffective among females and bronchial disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Lexapro and Tremfya. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Lexapro?

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,464 Lexapro users. Check the latest studies of Lexapro.

What is Tremfya?

Tremfya has active ingredients of guselkumab. eHealthMe is studying from 22,557 Tremfya users. Check the latest studies of Tremfya.



On Jul, 04, 2026

32 people who take Lexapro and Tremfya together, and have interactions are studied.

Lexapro and Tremfya drug interactions.

What are the common drug interactions of Lexapro and Tremfya, by gender? *:

female:

  1. Drug ineffective
  2. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  3. Psoriasis (immune-mediated disease that affects the skin)
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Injection site pain
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Peripheral coldness
  9. Respiratory disorder (respiratory disease)
  10. Heart rate decreased

male:

  1. Bronchial disorder
  2. Influenza like illness
  3. Pericardial effusion (fluid around the heart)
  4. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
  5. Chest discomfort
  6. Hypersensitivity
  7. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  8. Pruritus (severe itching of the skin)
  9. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  10. Sinusitis (inflammation of sinus)

What are the common drug interactions of Lexapro and Tremfya, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
  3. Disease recurrence
  4. Psoriasis (immune-mediated disease that affects the skin)
  5. Sleep disorder

40-49:

  1. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  2. Drug ineffective
  3. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Injection site pain
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Peripheral coldness
  8. Respiratory disorder (respiratory disease)
  9. Heart rate decreased
  10. Psoriasis (immune-mediated disease that affects the skin)

50-59:

  1. Arthralgia (joint pain)
  2. Injection site haemorrhage (bleeding from injection site)
  3. Psoriasis (immune-mediated disease that affects the skin)
  4. Chest discomfort
  5. Pruritus (severe itching of the skin)
  6. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)

60+:

  1. Bronchial disorder
  2. Drug ineffective
  3. Blood triglycerides increased
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Herpes simplex (herpes simplex is a common viral infection)
  6. Weight decreased
  7. Influenza like illness
  8. Psoriasis (immune-mediated disease that affects the skin)
  9. Constipation
  10. Gastric disorder (disease of stomach)

What are the existing conditions these people have? *

  1. Psoriasis (immune-mediated disease that affects the skin): 25 people, 78.12%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 8 people, 25.00%
  3. Stress And Anxiety: 4 people, 12.50%
  4. Inflammatory Bowel Disease: 2 people, 6.25%
  5. Heart Rate Increased: 2 people, 6.25%
  6. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Lexapro and Tremfya?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lexapro and Tremfya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lexapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tremfya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lexapro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tremfya and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate and guselkumab (the active ingredients of Lexapro and Tremfya, respectively), and Lexapro and Tremfya (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: